Description

Description

Empaglimet (12.5/1000mg) is a higher-strength combination diabetes tablet, pairing Empagliflozin with a larger dose of Metformin than the 12.5/500mg version. This dual-action formula brings together an SGLT2 inhibitor and a biguanide in a single tablet, offering a more substantial metformin dose for patients who need stronger support in controlling their blood sugar, alongside the added kidney-related glucose excretion effect of empagliflozin. It’s generally introduced once a doctor has assessed a patient’s need for a higher metformin dose within this combination. The pack contains 14 tablets and is intended for consistent, ongoing use as part of a long-term diabetes management plan.

Ingredients

Each Empaglimet (12.5/1000mg) tablet contains two active ingredients: Empagliflozin 12.5mg, an SGLT2 inhibitor, and Metformin Hydrochloride 1000mg, a biguanide. These are combined into a single tablet along with standard pharmaceutical excipients.

Dosage Form

This medicine is supplied as an oral tablet, meant to be swallowed whole with a full glass of water rather than crushed or chewed.

Uses

Empaglimet (12.5/1000mg) is used to improve blood sugar control in adults with type 2 diabetes mellitus who need a higher metformin dose within this combined treatment approach. Empagliflozin helps the kidneys remove excess glucose through urine, while the higher-dose Metformin component reduces glucose production in the liver, decreases intestinal glucose absorption, and improves the body’s sensitivity to insulin. Together, this combination provides synergistic blood sugar control, along with potential benefits for cardiovascular health and modest weight management, making it a common choice for patients with more significant glycemic control needs.

How to Use

Empaglimet (12.5/1000mg) is generally taken once daily, preferably with a meal to help enhance absorption and reduce the likelihood of stomach upset, as directed by a doctor. The tablet should be swallowed whole with a full glass of water rather than crushed or chewed. It’s important to follow the exact prescribed schedule, since dosing may be adjusted over time based on blood sugar levels and kidney function. If a dose is missed, it should be taken as soon as remembered, unless it’s close to the time of the next scheduled dose, in which case the missed dose should simply be skipped rather than doubled.

Side Effects

Commonly reported side effects include nausea, diarrhea, increased urination, and mild dehydration. Some patients may also notice a higher likelihood of urinary tract infections related to the empagliflozin component. Less commonly, more serious effects such as significant dehydration, severe urinary tract infections, or lactic acidosis can occur, and any of these — along with symptoms like severe muscle pain, unusual tiredness, or difficulty breathing — should be treated as a medical concern requiring prompt attention. Staying well hydrated is important while taking this medicine to help reduce the risk of dehydration-related side effects.

Pregnancy & Breastfeeding

Empaglimet is not recommended during pregnancy or while breastfeeding, as this combination is generally considered unsuitable for use in these circumstances. Anyone who is pregnant, planning a pregnancy, or breastfeeding should discuss alternative diabetes treatment options with their doctor rather than continuing or starting this medicine.

Storage Instructions

Store Empaglimet (12.5/1000mg) tablets at room temperature, away from direct heat, light, and moisture. Keep the tablets in their original packaging until needed, and store them safely out of reach of children. Any expired or unused tablets should be disposed of properly rather than through household waste.

FAQs

How does this strength differ from Empaglimet 12.5/500mg?
This version contains a higher metformin dose (1000mg instead of 500mg), while the empagliflozin dose stays the same, making it suitable for patients who need more metformin support.

Why is staying hydrated important with this medicine?
Because empagliflozin increases fluid loss through urine, adequate hydration helps reduce the risk of dehydration and related complications.

Can this medicine be used by someone with type 1 diabetes?
No, this combination is intended specifically for type 2 diabetes and is not recommended for type 1 diabetes.

What should I watch for that might indicate a serious problem?
Signs such as severe muscle pain, unusual fatigue, difficulty breathing, or severe dehydration should be reported to a doctor immediately, as these can indicate rare but serious complications.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.